Exploring the Role of Surgery After Systemic Therapy in Locally Advanced Biliary Tract Cancer: Outcomes From a Large Retrospective Multinational Real‐World Cohort Treated With Cisplatin, Gemcitabine, and Durvalumab
Margherita Rimini(Vita-Salute San Raffaele University), Gian Paolo Spinelli(Sapienza University of Rome), Lorenzo Antonuzzo(Azienda Ospedaliero-Universitaria Careggi), Stefano Tamberi(Azienda Unità Sanitaria Locale Della Romagna), Yoo Changhoon(University of Ulsan), Tiziana Pressiani(IRCCS Humanitas Research Hospital), Elisabetta Fenocchio(Candiolo Cancer Institute), Monica Verrico(Policlinico Umberto I), Oluseyi Abidoye(Mayo Clinic), Emiliano Tamburini(Ospedale Infermi di Rimini), Alessandro Pastorino(Ospedale Policlinico San Martino), Fabian Finkelmeier(Goethe University Frankfurt), Lucrezia Zumstein(Hospital Universitario 12 De Octubre), Alessandro Parisi(Marche Polytechnic University), Gerald W. Prager(Comprehensive Cancer Center Vienna), Lukas Perkhofer(University Hospital Ulm), Giovanni Farinea(University of Turin), Caterina Vivaldi(Scuola Superiore Sant'Anna), Florian Castet(Institut d'Investigació Biomédica de Bellvitge), C. Pinto(Harvard University), Vincenzo Formica(University of Rome Tor Vergata), Ilario Giovanni Rapposelli(Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori), Matteo Landriscina(University of Foggia), Chiara Braconi(Beatson West of Scotland Cancer Centre), Marta Schirripa(Azienda Sanitaria Locale Viterbo), Anna Diana(University of Campania "Luigi Vanvitelli"), Jessica Lucchetti(Campus Bio Medico University Hospital), Maria Grazia Rodriquenz(Casa Sollievo della Sofferenza), Ester Oneda(Fondazione Poliambulanza Istituto Ospedaliero), Hong Jae Chon(CHA University Bundang Medical Center), Salvatore Corallo(Fondazione IRCCS Istituto Nazionale dei Tumori), Ingrid Garajová(University of Parma), Federico Nichetti(Fondazione IRCCS Istituto Nazionale dei Tumori), Frederik Peeters, Antonio Avallone(Istituto Nazionale Tumori IRCCS "Fondazione G. Pascale"), Giuseppe Aprile(Ospedale Santa Maria della Misericordia di Udine), A. Martirena(Hospital Universitario Fundación Jiménez Díaz), Jin Won Kim(Seoul National University Bundang Hospital), Il Hwan Kim(Inje University Haeundae Paik Hospital), David J. Pinato(Hammersmith Hospital), Anna Saborowski(Medizinische Hochschule Hannover), Mario Scartozzi(University of Cagliari), Beodeul Kang(CHA University Bundang Medical Center), Masafumi Ikeda(National Cancer Center Hospital East), Angela Lamarca(Hospital Universitario Fundación Jiménez Díaz), Chiara Pircher(Fondazione IRCCS Istituto Nazionale dei Tumori), Michele Ghidini(Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico), Nuno Couto(Champalimaud Foundation), Arndt Vogel(Princess Margaret Cancer Centre), Emanuela Dell’Aquila(Università Campus Bio-Medico)
Cited by 0
Related Papers
Cholangiocarcinoma 2020: the next horizon in mechanisms and management
|Nature Reviews Gastroenterology & Hepatology|2020|2.5k
Patient-derived organoids model treatment response of metastatic gastrointestinal cancers
|Science|2018|2.1k
NASH limits anti-tumour surveillance in immunotherapy-treated HCC
|Nature|2021|1.3k
Durvalumab plus Gemcitabine and Cisplatin in Advanced Biliary Tract Cancer
|NEJM Evidence|2022|1.1k